'Nrti resistance' presentation slideshows

Dr Ed Wilkins

965 views • 81 slides

Failure of Antiretroviral Therapy and Subsequent Treatment Options

Failure of Antiretroviral Therapy and Subsequent Treatment Options. Rafael E. Campo, MD Associate Professor of Medicine University of Miami Leonard M. Miller School of Medicine and Jackson Memorial Hospital Miami, FL rcampo@med.miami.edu.

504 views • 38 slides

Of Mothers, Orphans and the HIV Pandemic

Of Mothers, Orphans and the HIV Pandemic. Karen P. Beckerman, MD Associate Professor of Obstetrics and Gynecology New York University Director of Obstetrics Bellevue Hospital Center 25 October 2002. New slides needed: CSx data: 367, 316, Models of HIV Rx in dev world

374 views • 29 slides

PENPACT 1 (PENTA 9 / PACTG 390)

402 views • 26 slides

Structural Basis for HIV-1 Reverse Transcriptase Drug Resistance to Zidovudine (AZT) and Tenofovir

Structural Basis for HIV-1 Reverse Transcriptase Drug Resistance to Zidovudine (AZT) and Tenofovir. Kalyan Das CABM & Rutgers University, NJ, USA. NRTI - Inhibition and Resistance. NRTI Inhibition Nucleoside/nucleotide analog

459 views • 20 slides

IAS 2019, Mexico City

Switching to a Single-tablet Regimen of Bictegravir , Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) from Dolutegravir plus Either F/TAF or F/TDF.

499 views • 19 slides

Analysis of recent trials/cohort on resistance in Africa

Analysis of recent trials/cohort on resistance in Africa. Annemarie Wensing, MD, PhD. Disclaimer. 10 minutes presentation Not a complete overview on development of resistance in Africa Highlight a selection of interesting data & developments.

274 views • 17 slides

Guidelines published as an update on 2003 guidelines. About 8-9 pages. New data only

174 views • 8 slides

Comparison of NNRTI vs PI/r

186 views • 5 slides